Ohio Appalachia Public Health Department Personnel: Human Papillomavirus (HPV) Vaccine Availability, and Acceptance and Concerns Among Parents of Male and Female Adolescents
Purchase on Springer.com
$39.95 / €34.95 / £29.95*
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.
Public health departments (n = 48) serving the 32 counties of Ohio Appalachia were contacted to determine human papillomavirus (HPV) vaccine availability and to assess patient and parental attitudes, perceived barriers, and decisional differences about vaccination for male and female adolescents. Nurses or nursing supervisors in 46 of 48 health departments agreed to participate with 45 (97.8 %) reporting that HPV vaccines were available for males and females. HPV vaccination barriers reported most frequently were lack of knowledge about the vaccines, concerns about potential side effects, the newness of the HPV vaccines, and parents believing their children were not sexually active or were too young to receive an HPV vaccine. Provider reports of the primary differences in the acceptability of an HPV vaccine among parents of males compared to the parents of females were lack of awareness that an HPV vaccine was available for males, not understanding why the vaccine should be given to males, and fear of vaccination increasing sexual promiscuity among female adolescents. Half of the health departments (n = 24) reported that parents of females were more receptive toward HPV vaccination, 16 health departments reported no difference in acceptability based on gender of the child, and 5 health departments reported that parents of males were more receptive. This study suggests that there are different informational needs of males and females and parents of male and female children when making an informed decision about HPV vaccination. Findings highlight content to include in strategies to increase HPV vaccination rates among Appalachia Ohio residents.
- Hariri, S., Unger, E. R., Sternberg, M., et al. (2011). Prevalence of genital human papillomavirus among females in the United States, the National Health and Nutrition Examination Survey, 2003–2006. Journal of Infectious, 204(4), 566–573. CrossRef
- Nyitray, A. G., da Silva, R. J., Baggio, M. L., et al. (2011). The prevalence of genital HPV and factors associated with oncogenic HPV among men having sex with men and men having sex with women and men: The HIM study. Sexually Transmitted Diseases, 38(10), 932–940. CrossRef
- Walboomers, J. M., Jacobs, M. V., Manos, M. M., et al. (1999). Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. Journal of Pathology, 189(1), 12–19. CrossRef
- Munoz, N., Castellsague, X., de Gonzalez, A. B., & Gissmann, L. (2006). Chapter 1: HPV in the etiology of human cancer. Vaccine, 24(Suppl 3), S3/1–S3/10.
- Lacey, C. J., Lowndes, C. M., & Shah, K. V. (2006). Chapter 4: Burden and management of non-cancerous HPV-related conditions: HPV-6/11 disease. Vaccine, 24(Suppl 3), 35–41. CrossRef
- Gillison, M. L., Chaturvedi, A. K., & Lowy, D. R. (2008). HPV prophylactic vaccines and the potential prevention of noncervical cancers in both men and women. Cancer, 113(10 Suppl), 3036–3046. CrossRef
- Huang, B., Wyatt, S. W., Tucker, T. C., Bottorff, D., Lengerich, E., & Hall, H. I. (2002). Cancer death rates–Appalachia, 1994–1998. MMWR: Morbidity and Mortality Weekly Report, 51(24), 527–529.
- Hopenhayn, C., Bush, H., Christian, A., & Shelton, B. J. (2005). Comparative analysis of invasive cervical cancer incidence rates in three Appalachian states. Preventative Medicine, 41(5–6), 859–864. CrossRef
- Lengerich, E. J., Tucker, T. C., Powell, R. K., et al. (2005). Cancer incidence in Kentucky, Pennsylvania, and West Virginia: Disparities in Appalachia. Journal of Rural Health, 21(1), 39–47. CrossRef
- Hopenhayn, C., King, J. B., Christian, A., Huang, B., & Christian, W. J. (2008). Variability of cervical cancer rates across 5 Appalachian states, 1998–2003. Cancer, 113(10 Suppl), 2974–2980. CrossRef
- Wingo, P. A., Tucker, T. C., Jamison, P. M., et al. (2008). Cancer in Appalachia, 2001–2003. Cancer, 112(1), 181–192. CrossRef
- Marmot, M., & Wilkinson, R. G. (2005). Social determinants of health. New York, NY: Oxford University Press. CrossRef
- Warnecke, R. B., Oh, A., Breen, N., et al. (2008). Approaching health disparities from a population perspective: The National Institutes of Health Centers for Population Health and Health Disparities. American Journal of Public Health, 98(9), 1608–1615. CrossRef
- Wewers, M. E., Katz, M., Fickle, D., & Paskett, E. D. (2006). Risky behaviors among Ohio Appalachian adults. Preventing Chronic Disease, 3(4), A127.
- Yabroff, K. R., Lawrence, W. F., King, J. C., et al. (2005). Geographic disparities in cervical cancer mortality: What are the roles of risk factor prevalence, screening, and use of recommended treatment? Journal of Rural Health, 21(2), 149–157. CrossRef
- Katz, M. L., Wewers, M. E., Single, N., & Paskett, E. D. (2007). Key informants’ perspectives prior to beginning a cervical cancer study in Ohio Appalachia. Qualitative Health Research, 17(1), 131–141. CrossRef
- Schoenberg, N. E., Hopenhayn, C., Christian, A., Knight, E. A., & Rubio, A. (2005). An in-depth and updated perspective on determinants of cervical cancer screening among central Appalachian women. Journal of Women’s Health, 42(2), 89–105.
- Lyttle, N. L., & Stadelman, K. (2006). Assessing awareness and knowledge of breast and cervical cancer among Appalachian women. Preventing Chronic Disease, 3(4), A125.
- Markowitz, L. E., Dunne, E. F., Saraiya, M., Lawson, H. W., Chesson, H., & Unger, E. R. (2007). Quadrivalent Human Papillomavirus Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR: Recommendations and Reports, 56(RR-2), 1–24.
- Centers for Disease Control and Prevention. (2010). FDA licensure of bivalent human papillomavirus vaccine (HPV2, Cervarix) for use in females and updated HPV vaccination recommendations from the Advisory Committee on Immunization Practices (ACIP). MMWR: Morbidity and Mortality Weekly Report, 59(20), 626–629.
- Centers for Disease Control and Prevention. (2010). FDA licensure of quadrivalent human papillomavirus vaccine (HPV4, Gardasil) for use in males and guidance from the Advisory Committee on Immunization Practices (ACIP). MMWR: Morbidity and Mortality Weekly Report, 59(20), 630–632.
- Usher, W. T. (2012). Australian health professionals’ social media (Web 2.0) adoption trends: Early 21st century health care delivery and practice promotion. Australian Journal of Primary Health, 18(1), 31–41. CrossRef
- Centers for Disease Control and Prevention. (2011). Recommendations on the use of quadrivalent human papillomavirus vaccine in males—Advisory Committee on Immunization Practices (ACIP). MMWR: Morbidity and Mortality Weekly Report, 60(50), 1705–1708.
- Dorell, C., Stokley, S., Yankey, D., Liang, J., & Markowitz, L. (2010). National and state vaccination coverage among adolescents aged 13 through 17 years—United States. MMWR: Morbidity and Mortality Weekly Report, 60(33), 1117–1123.
- Reiter, P. L., McRee, A. L., Kadis, J. A., & Brewer, N. T. (2011). HPV vaccine and adolescent males. Vaccine, 29(34), 5595–5602. CrossRef
- Abramson, R., & Haskell, J. (2006). Encyclopedia of Appalachia. Knoxville, TN: University of Tennessee Press.
- Campos-Outcalt, D., Jeffcott-Pera, M., Carter-Smith, P., Schoof, B. K., & Young, H. F. (2010). Vaccines provided by family physicians. The Annals of Family Medicine, 8(6), 507–510. CrossRef
- Katz, M. L., Reiter, P. L., Kluhsman, B. C., et al. (2009). Human papillomavirus (HPV) vaccine availability, recommendations, cost, and policies among health departments in seven Appalachian states. Vaccine, 27(24), 3195–3200. CrossRef
- Omurtag, K., Jimenez, P. T., Ratts, V., Odem, R., & Cooper, A. R. (2012). The ART of social networking: How SART member clinics are connecting with patients online. Fertility and Sterility, 97(1), 88–94. CrossRef
- Ohio Department of Health. (2012). Ohio Department of Health. Retrieved August 24, 2012, from http://www.odh.ohio.gov/.
- Miles, M. B., & Huberman, A. M. (1994). Qualitative data analysis: An expanded sourcebook. Thousand Oaks, CA: Sage Publications.
- Ohio Department of Health. (2012). Immunization summary for child care, head start, pre-school and school attendance. Ohio Administrative Code 5101:2-12-37 and Ohio Revised Code 3313.671 for school attendance. Retrieved August 24, 2012, from http://www.odh.ohio.gov/~/media/ODH/ASSETS/Files/immunizations/immunizationsummary-childcareschool12.ashx.
- Vadaparampil, S. T., Kahn, J. A., Salmon, D., et al. (2011). Missed clinical opportunities: Provider recommendations for HPV vaccination for 11–12 year old girls are limited. Vaccine, 29(47), 8634–8641. CrossRef
- Daley, E. M., Vamos, C. A., Buhi, E. R., et al. (2010). Influences on human papillomavirus vaccination status among female college students. Journal of Women’s Health, 19(10), 1885–1891. CrossRef
- Conroy, K., Rosenthal, S. L., Zimet, G. D., et al. (2009). Human papillomavirus vaccine uptake, predictors of vaccination, and self-reported barriers to vaccination. Journal of Women’s Health, 18(10), 1679–1686. CrossRef
- Fernandez, M. E., Allen, J. D., Mistry, R., & Kahn, J. A. (2010). Integrating clinical, community, and policy perspectives on human papillomavirus vaccination. Annual Review of Public Health, 31, 235–252. CrossRef
- Zimet, G. D., Weiss, T. W., Rosenthal, S. L., Good, M. B., & Vichnin, M. D. (2010). Reasons for non-vaccination against HPV and future vaccination intentions among 19–26 year-old women. BMC Women’s Health, 10, 27.
- Ford, C. A., English, A., Davenport, A. F., & Stinnett, A. J. (2009). Increasing adolescent vaccination: Barriers and strategies in the context of policy, legal, and financial issues. Journal of Adolescent Health, 44(6), 568–574. CrossRef
- Jain, N., Euler, G. L., Shefer, A., Lu, P., Yankey, D., & Markowitz, L. (2009). Human papillomavirus (HPV) awareness and vaccination initiation among women in the United States, National Immunization Survey-Adult 2007. Preventive Medicine, 48(5), 426–431. CrossRef
- Caskey, R., Lindau, S. T., & Alexander, G. C. (2009). Knowledge and early adoption of the HPV vaccine among girls and young women: Results of a national survey. Journal of Adolescent Health, 45(5), 453–462. CrossRef
- Reiter, P. L., Brewer, N. T., & Smith, J. S. (2010). Human papillomavirus knowledge and vaccine acceptability among a national sample of heterosexual men. Sexually Transmitted Infections, 86(3), 241–246. CrossRef
- Zimet, G. D., & Rosenthal, S. L. (2010). HPV vaccine and males: Issues and challenges. Gynecologic Oncology, 117(2 Suppl), S26–S31. CrossRef
- Katz, M. L., Krieger, J. L., & Roberto, A. J. (2011). Human papillomavirus (HPV): College male’s knowledge, perceived risk, sources of information, vaccine barriers and communication. Journal of Men’s Health, 8(3), 175–184. CrossRef
- Berenson, A. B., & Rahman, M. (2012). Gender differences among low income women in their intent to vaccinate their sons and daughters against human papillomavirus infection. Journal of Pediatric and Adolescent Gynecology, 25(3), 218–220. CrossRef
- Ohio Appalachia Public Health Department Personnel: Human Papillomavirus (HPV) Vaccine Availability, and Acceptance and Concerns Among Parents of Male and Female Adolescents
Journal of Community Health
Volume 37, Issue 6 , pp 1157-1163
- Cover Date
- Print ISSN
- Online ISSN
- Springer US
- Additional Links
- HPV vaccines
- Cervical cancer
- Health care disparities
- Appalachian region
- Author Affiliations
- 1. College of Public Health, The Ohio State University, Suite 525, 1590 North High Street, Columbus, OH, 43201, USA
- 2. Division of Cancer Prevention and Control, Department of Internal Medicine, College of Medicine, The Ohio State University, Columbus, OH, USA
- 3. Comprehensive Cancer Center, The Ohio State University, Columbus, OH, USA